In-depth analysis of Breast Cancer care across the EU28
FutureProofing Healthcare: The Breast Cancer Index is an additional, in-depth analysis of the state of care for breast cancer across the EU 28 member states. Over the past twenty years, breast cancer has taken huge strides forward in treatment and care with positive results in outcomes and survivorship. It is a paradigm that should be applied to other areas of healthcare. Breast cancer is also one of the most prevalent cancers with significant data publically available from all 28 EU member states.
The Breast Cancer Index, which was led by an independent panel of healthcare experts from across the EU, with the support of Roche, measured five Vital Signs representing different stages of the patient experience:
- Prevention & Diagnosis
- Outcomes & Survivorship
- Patient Focus
- Treatment
- Palliative Care
FutureProofing Healthcare aims to start an EU-wide conversation on the need to create sustainable healthcare systems that will meet the needs of patients in the years to come.
How will you join this conversation?
#FutureProofIndex
